BA
TRIV

BlackRock Advisors’s TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK TRIV Stock Holding History

BlackRock Advisors’s Portfolio TRIV Stock Details TRIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-3,749
Closed -$39K – 3785
2015
Q1 		$39K Buy
3,749
+979
+35% +$10.1K ﹤0.01% 3306
2014
Q4 		$35K Sell
2,770
-386
-12% -$5.26K ﹤0.01% 3361
2014
Q3 		$46K Buy
+3,156
New +$45.8K ﹤0.01% 3290

Other funds holding TRIV

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock Advisors's TRIV Position: Q2 2015 in Review

BlackRock Advisors sold out of TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) in Q2 2015, closing a stake of 3,749 shares — an estimated $39K sold.

BlackRock Advisors first reported a position in TRIV in Q3 2014 and held it in 3 quarters. The position peaked at $46K in Q3 2014. 36 funds tracked by Wall St. Rank hold TRIV as of Q2 2015.

  • BlackRock Advisors reported no remaining TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position as of Q2 2015 after selling out during the quarter.
  • BlackRock Advisors sold 3,749 TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK shares in Q2 2015, an estimated $39K.
  • BlackRock Advisors first reported a position in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK in Q3 2014 and held it in 3 quarters.
  • BlackRock Advisors's TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position peaked at $46K in Q3 2014.
  • 36 funds tracked by Wall St. Rank held TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK as of Q2 2015.

Based on BlackRock Advisors's 13F filing for Q2 2015, filed 7 Aug 2015.